AUSTIN — Debate over a proposal that would eliminate Texans’ access to abortion pills dominated a legislative hearing Friday. Rep. Jeff Leach, R-Allen, laid out a revised version of a bill ...

And she’s close—or at least, she claims to be. In February 2025, LOY-002—a prescription pill from Loyal designed to extend healthy lifespan in senior dogs of nearly every size by targeting ...

Now, a new contender is stepping into the spotlight. It’s called Orforglipron, and it’s a daily weight loss pill that could be a game-changer in how we manage both weight and blood sugar.

Novo Nordisk A/S slumped amid concern that a weight-loss pill from rival Eli Lilly & Co. will steal market share from bestsellers such as its injected blockbuster Ozempic. The stock dropped as ...

Investing.com -- Novo Nordisk (NYSE:NVO) shares sank more than 7% in Copenhagen after Eli Lilly (NYSE:LLY) released promising trial results for its experimental obesity pill, orforglipron ...

Patients are being warned to routinely review the pills they take, especially those available over the counter, as one could be interfering with blood pressure-lowering efforts. Around nine per ...

The launch of PADCEV TM reinforces Astellas’ commitment to expanding its oncology portfolio in India. Following the introduction of Xospata TM (Gilteritinib) last April for relapsed or ...

Before the Trodelvy readout, a combination of Pfizer and Astellas’ Nectin-4 ADC Padcev and Keytruda won a full FDA approval in late 2023 as a first-line treatment for advanced bladder cancer.

It positions the pharma to dominate the oral GLP-1 market. The pill achieved 7.9% weight loss (16 pounds) and 1.3% to 1.6% A1C reduction in diabetes patients over 40 weeks, rivaling Novo Nordisk ...

If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. What if a pill meant to help you sleep could also protect your brain from one of the ...

Forget injections. A new drug promises to be just as effective as Ozempic — but is taken as a daily pill. Called orforglipron, the results of a new clinical trial announced Thursday by ...